- Home
- YMM vs BAX Comparison
YMM vs BAX Comparison
Compare YMM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YMM | BAX |
|---|---|---|
| Founded | 2011 | 1931 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 9.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | YMM | BAX |
|---|---|---|
| Price | $11.51 | $18.60 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 10 |
| Target Price | $12.67 | ★ $25.67 |
| AVG Volume (30 Days) | 7.0M | ★ 8.3M |
| Earning Date | 11-17-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.67% | 0.22% |
| EPS Growth | ★ 29.34 | N/A |
| EPS | ★ 0.53 | N/A |
| Revenue | $1,751,813,549.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $11.64 | $5.20 |
| Revenue Next Year | $8.97 | $2.02 |
| P/E Ratio | $21.94 | ★ N/A |
| Revenue Growth | ★ 19.09 | 3.90 |
| 52 Week Low | $9.45 | $17.40 |
| 52 Week High | $14.07 | $37.74 |
Technical Indicators
Market Signals| Indicator | YMM | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.00 | 43.20 |
| Support Level | $11.24 | $18.33 |
| Resistance Level | $11.44 | $19.17 |
| Average True Range (ATR) | 0.36 | 0.54 |
| MACD | 0.08 | 0.21 |
| Stochastic Oscillator | 95.59 | 63.23 |
Price Performance
Historical ComparisonAbout YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.